Evidence map›Paper›PMID 38862459›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2024

[Analysis of

Y Zhou, Y Wu, H Zeng, C Chen, Q Xie, L He

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Advances in diagnostic assays forFrontiers in cellular and infection microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Y ZhouSchool of Public Health, Xiangnan University, Chenzhou 423000, China.
Y WuNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
H ZengSchool of Public Health, Xiangnan University, Chenzhou 423000, China.
C ChenSchool of Public Health, Xiangnan University, Chenzhou 423000, China.
Q XieSchool of Public Health, Xiangnan University, Chenzhou 423000, China.
L HeSchool of Public Health, Xiangnan University, Chenzhou 423000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the characteristics of

methodsStool samples were collected from 306 patients with diarrhea hospitalized in 3 university hospitals in a mid-south city of China from October to December, 2020.

resultsCDI was detected in 25 (8.17%) out of the 306 patients. All the patients tested positive for

conclusionThe CDI rate remains low in the hospitalized patients with diarrhea in the investigated hospitals, but early precaution measures are recommended when exposure to the risk factors is reported to reduce the risk of CDI in the hospitalized patients.

Indexed as

Clostridioides difficileClostridium InfectionsDiarrheaHospitals, UniversityMultilocus Sequence TypingAnti-Bacterial AgentsBacterial ProteinsBacterial ToxinsChinaEnterotoxinsFecesFemaleHospitalizationHumansMaleMiddle AgedAnti-Bacterial AgentsBacterial ProteinsBacterial ToxinsEnterotoxinstcdA protein, Clostridium difficiletoxB protein, Clostridium difficileClostridioides difficiledrug resistancemultilocus sequence typingrisk factorstoxin gene

Identifiers

PMID38862459
PMCPMC11166708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.